11 march 2022
Corrigendum to: ‘A genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkers’ [J Hepatol 2022 (76) 275-282]
No abstract available
Erratum for
-
A genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkers.J Hepatol. 2022 Feb;76(2):275-282. doi: 10.1016/j.jhep.2021.10.005. Epub 2021 Oct 14.PMID: 34656649
Additional Info
-
Authors
Seth D.; Naveau S.; Perney P.; Botwin G.; Haber P. S.; Seitz H. K.; Day C. P.; Daly A. K.; Cordell H. J.; Whitfield J. B.; Morgan T. R.; Nahon P.; Genom A. L. C. Consortium; Atkinson S. R.; Chalasani N. P.; Foroud T.; McQuillin A.; Morgan M. Y.; Mullhaupt B.; Thursz M. R.; Trepo E.; Eyer F.; Moreno C.; Liangpunsakul S.; Nagy L. E.; Bataller R.; Stickel F.; Schwantes-An T. H.; Darlay R.; Mathurin P.; Mueller S.; Aithal G. P.; Masson S.; Gleeson D.; Thompson A.; Soyka M.; Goldman D.; Liang T.; Pirmohamed M.; Nalpas B.; Jacquet J. M.; Moirand R. -
Issue
J Hepatol . 2022 Mar 11;S0168-8278(22)00117-9 -
Published Date
11 march 2022
Related items
- Impact of alcohol consumption and muscle mass on bone mineral density in metabolic dysfunction and alcohol-associated liver disease (MetALD) and metabolic dysfunction-associated steatotic liver disease (MASLD)
- Review Article: Impact of Alcohol Consumption on the Development and Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease
- Impact of alcohol consumption and muscle mass on bone mineral density in metabolic dysfunction and alcohol-associated liver disease (MetALD) and metabolic dysfunction-associated steatotic liver disease (MASLD)
- The Role of the Mediterranean Diet and Alcohol Consumption in Chronic Liver Disease Prevention: A Narrative Review
- Effects of alcohol consumption on the prevalence and incidence of non-alcoholic fatty liver disease: A systematic review and meta-analysis